53.80 USD
↘ 2.33 (4.15%)LIVE (AS OF 11:50 AM EST)
Shares of Cytokinetics Inc. (CYTK) are trading at $53.80. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (242.2%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, CYTK is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 13, 2026.